Health & Regulatory Affairs Committee

Co-Chair: Steven Mento, Co-Founder, President, CEO, & Chairman, Conatus Pharmaceuticals, Inc.
Co-Chair: Hal Van Wart, President & CEO, CymaBay Therapeutics
Staff Contact: Cartier Esham, Executive Vice President, Emerging Companies, cesham(at)bio.org.   

Description:  Review and develop as appropriate priorities on healthcare policy and regulatory matters affecting emerging companies. Work in conjunction with BIO’s Health Section standing committees on policy development and the inclusion of emerging company priorities and views with respect thereto.

Members:
Adelene Perkins, President & CEO, Infinity Pharmaceuticals, Inc.
Arlene Morris, Chief Executive Officer, Syndax Pharmaceuticals, Inc.
Carlos Paya, President & CEO, Immune Design
Deborah Dunsire, President & CEO, FORUM Pharmaceuticals, Inc.
Gil Van Bokkelen, Chairman & CEO, Athersys, Inc.
Hans Schikan, Chief Executive Officer, Prosensa, Inc.
Jeffrey Hatfield, President & CEO, Vitae Pharmaceuticals, Inc.
Jim Healy, General Partner, Sofinnova Ventures
John Maraganore, Chief Executive Officer, Alnylam Pharmaceuticals, Inc.
John Mendlein, President, CEO & Chairman, aTyr Pharma, Inc.
John Orwin, President & CEO, Relypsa, Inc.
Jean Francois Formela, Partner, Atlas Ventures
Jonathan Leff, Partner & Chairman, Deerfield Management Company, LP
Kristine Peterson, Chief Executive Officer, Valeritas, Inc.
Marc Beer, Chief Executive Officer, Aegerion Pharmaceuticals, Inc.
Mark Pruzanski, Founder, President & CEO, Intercept Pharmaceuticals, Inc.
Martin Babler, Chief Executive Officer, Principia Biopharma
Maxine Gowen, President & CEO, Trevena, Inc.
Mike Narachi, President & CEO, Orexigen Therapeutics, Inc.
Moncef Sloaui, Chairman, Global Vaccines, GlaxoSmithKline, plc
Neil Warma, President & CEO, Opexa Therapeutics, Inc.
Nick Leschly, President & CEO, bluebird bio
Paul Hastings, President & CEO, OncoMed Pharmaceuticals, Inc.
Peter Greenleaf, Chief Executive Officer, Sucampo Pharmaceuticals, Inc.
Robert Kiss, Managing Director & Portfolio Manager, JPMorgan Asset Management
Ron Cohen, President & CEO, Acorda Therapeutics, Inc.
Russell Herndon, President & CEO, Hydra Biosciences, Inc.
Scott Koenig, President & CEO, MacroGenics, Inc.
Stuart Peltz, President & CEO, PTC Therapeutics, Inc.
Thomas Mathers, Chief Executive Officer, CoLucid Pharmaceuticals, Inc.
Timothy Rodell, CEO & President, GlobeImmune, Inc.
Timothy Walbert, Chairman, President & CEO, Horizon Pharma, Inc.